Cytoreason

Cytoreason is an Israeli computational biology company focused on disease modeling using machine learning. The company builds cell-population models of human disease — essentially large-scale computational representations of how different cell types in diseased tissue interact — to help pharmaceutical companies understand mechanisms of disease and predict drug response.

Cytoreason's primary offering is a disease model platform that analyzes gene expression and other omics data to generate cell-type-resolved maps of biological processes in conditions such as rheumatoid arthritis, inflammatory bowel disease, and other immune-mediated diseases. The buyers are R&D teams at large pharmaceutical and biotech companies, who use the models to prioritize drug targets, select patient populations, and interpret clinical trial data. Pfizer was publicly named as a collaboration partner, which gave the company notable credibility in the biopharma industry.

Cytoreason is headquartered in Tel Aviv. Detailed public information on headcount, office locations beyond Tel Aviv, and hiring functions is limited.